Consulting on drug development and toxicology for neurological diseases
NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICES
This study is all about getting expert help to make sure new treatments for neurological diseases are safe and effective before they reach patients, so we can better understand and tackle any challenges that come up during their development.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Certara USA, INC. NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11175936 on NIH RePORTER |
What this research studies
This research involves expert consultants providing guidance on drug development and toxicology specifically for neurological diseases. They will help establish important toxicology endpoints, recommend bioassays, and design studies to ensure the safety and efficacy of new treatments. The consultants will collaborate with NIH staff and other experts to optimize drug candidates and support their progression from preclinical stages to initial clinical trials. This work aims to enhance the understanding of potential developmental challenges and improve strategies for addressing them.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with neurological diseases who may be affected by new drug therapies developed through this program.
Not a fit: Patients with non-neurological conditions are unlikely to receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for patients with neurological disorders.
How similar studies have performed: Previous research in drug development for neurological diseases has shown promise, indicating that this approach could yield beneficial results.
Where this research is happening
Saint Louis, United States
- Certara USA, INC. — Saint Louis, United States (Active)
Researchers
- Principal investigator: Duddy, Steve — Certara USA, INC.
- Study coordinator: Duddy, Steve
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.